301 CARLSON PARKWAY, MINNEAPOLIS, MN
Market cap: $434.8M (12/22/2025)
Price: $8.35
Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
Reports Third Quarter 2025 Financial Results and Provides Business Highlights
News
Earnings Release
Appoints Julie Krop, MD, as Chief Medical Officer
Raises $30 Million in Private Placement to Accelerate Industry Leading Preeclampsia and Fetal Growth Restriction Pipeline
Investor Presentation
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus Filed Pursuant to Rule 424(b)(2)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload